Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Heron Therapeutics

Clinical trials sponsored by Heron Therapeutics, explained in plain language.

Heron Therapeutics HRTX NASDAQ

A commercial-stage biopharmaceutical company developing treatments for pain and cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 16 Terminated 1

Could a nausea drug help fight COVID-19? early trial cut short

Disease control Terminated

This phase 2 trial tested whether adding aprepitant, a drug usually used for nausea, to standard care could help hospitalized COVID-19 patients recover faster. The study planned to enroll adults recently admitted to the hospital with COVID-19 and signs of lung involvement. Howeve…

Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC